Cargando…
A Novel Mutation in Lafora Disease and Update on Pathophysiology and Future Treatments
Lafora disease is a rare refractory epilepsy that results in death. This report highlights two cases of lafora disease and introduces a novel mutation in the patients. A review of the pathophysiology and future therapies is reviewed.
Autores principales: | Nordli, Douglas R., Rao, Chethan K., Delgado-Escueta, Antonio V., Galan, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537485/ https://www.ncbi.nlm.nih.gov/pubmed/36211619 http://dx.doi.org/10.1177/2329048X221126361 |
Ejemplares similares
-
Role of Astrocytes in the Pathophysiology of Lafora Disease and Other Glycogen Storage Disorders
por: Duran, Jordi
Publicado: (2023) -
Progressive Myoclonic Epilepsy Due to Lafora Body Disease with a Novel Mutation
por: Israni, Anil V., et al.
Publicado: (2018) -
Ketogenic diet reduces Lafora bodies in murine Lafora disease
por: Israelian, Lori, et al.
Publicado: (2020) -
Lafora disease: a case report
por: Zeka, Naim, et al.
Publicado: (2022) -
Everolimus does not prevent Lafora body formation in murine Lafora disease
por: Mishra, Navin, et al.
Publicado: (2017)